Results 181 to 190 of about 23,162 (241)

Lipoxygenase inhibitors for the treatment of pancreatic cancer

Expert Review of Anticancer Therapy, 2003
Pancreatic cancer has a dismal prognosis with no effective medical therapy. Therefore, there is a need to search for novel targets for cancer prevention and treatment. The lipoxygenases oxygenate arachidonic acid and other 20-carbon fatty acids and their downstream metabolites have been found to mediate several aspects of pancreatic cancer development ...
Thomas Adrian   +2 more
exaly   +3 more sources

Silymarin, an inhibitor of lipoxygenase

Experientia, 1979
Silybin (I), silydianin (II) and silychristin (III), the constituents of silymarin, non-competitively inhibit the lipoxygenase from soybeans (EC 1.13.11.12) in vitro.
F, Fiebrich, H, Koch
openaire   +2 more sources

Anthocyanins as lipoxygenase inhibitors

Molecular Nutrition & Food Research, 2009
AbstractHealth benefits associated with diets rich in anthocyanins are ascribed to multilevel biological activities including antioxidative and anti‐inflammatory effects. The present study addresses lipoxygenase inhibition as a mechanism by which anthocyanins may exert health promoting effects. The inhibitory potential of delphinidin (Dp), cyanidin (Cy)
Bastian, Knaup   +3 more
openaire   +2 more sources

Review: lipoxygenase inhibitors and the gut

Alimentary Pharmacology & Therapeutics, 1987
SUMMARYLeukotriene synthesis is influenced by several drugs currently in use for the treatment of alimentary disease, including the corticosteroids, sulphasalazine and mesalazine. However, the use of selective lipoxygenase inhibitors in human gastrointestinal disease has not been investigated. The complexity of eicosanoid metabolism, and the incomplete
N P, Kennedy, P W, Keeling
openaire   +2 more sources

Episulfide inhibitors of lipoxygenase

Bioorganic & Medicinal Chemistry Letters, 1992
Abstract A set of epoxide and episulfide substrate mimics were synthesized as inhibitors of soybean lipoxygenase. Enzyme inhibition was observed exclusively with the 12,13-episulfides (1a and 4a), with a high degree of regio- and chemoselectivity. Inhibition by 1a was shown to occur with reduction of the enzyme active site iron from the catalytically
Stephen W. Wright, Mark J. Nelson
openaire   +1 more source

15-Lipoxygenase inhibitors: a patent review

Expert Opinion on Therapeutic Patents, 2015
15-Lipoxygenases (15-LOXes) are a family of iron-containing proteins that have the capability for unsaturated fatty acid peroxidation in animals and plants. Two types of the enzyme, 15-LOX-1 and 15-LOX-2, have been recognized in mammals to have different abilities in the peroxidation of arachidonic acid and linoleic acid.
Hamid, Sadeghian, Atena, Jabbari
openaire   +2 more sources

Hydroxamic acid inhibitors of 5-lipoxygenase

Journal of Medicinal Chemistry, 1987
The hydroxamic acid functionality can be incorporated in a variety of simple molecules to produce potent inhibitors of 5-lipoxygenase. As an example of this, the structure-activity relationships in a series of omega-phenylalkyl and omega-naphthylalkyl hydroxamic acids are presented. Among the features described are the influence of hydrophobicity, aryl
J B, Summers   +5 more
openaire   +2 more sources

4-Hydroxythiazole inhibitors of 5-lipoxygenase

Journal of Medicinal Chemistry, 1991
4-Hydroxythiazoles have been identified as potent inhibitors of 5-lipoxygenase in vitro exhibiting IC50's of less than 1 microM. An investigation of structure-activity relationships showed that the most potent inhibitors of this series are the 5-phenyl derivatives. The corresponding thiazolidin-4-one analogues were found to be relatively inactive.
F A, Kerdesky   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy